🇺🇸 FDA
Patent

US 10814043

Cross-linked fatty acid-based biomaterials

granted A61KA61K31/4353A61P

Quick answer

US patent 10814043 (Cross-linked fatty acid-based biomaterials) held by ATRIUM MEDICAL CORPORATION expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ATRIUM MEDICAL CORPORATION
Grant date
Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/4353, A61P, A61P29/00, A61P35/00